NCT05040594View on ClinicalTrials.gov

Evaluate the Efficacy and Safety of Lidocaine-Containing Hyaluronic Acid Filler in the Treatment of Nasolabial Folds.

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

December 26, 2019

Primary Completion Date

October 15, 2020

Study Completion Date

November 5, 2020

Conditions
Wrinkles Such as Nasolabial Folds
Interventions
DEVICE

PavéDerm J-Fill Soft Dermal Filler

Sodium Hyaluronate 20 mg with Lidocaine hydrochloride 3 mg/mL

DEVICE

Restylane® Lyft Lidocaine

Sodium Hyaluronate 20 mg with Lidocaine hydrochloride 3 mg/mL

Trial Locations (1)

Unknown

Taipei Veterans General Hospital, Taipei

All Listed Sponsors
lead

Yung Shin Pharm. Ind. Co., Ltd.

INDUSTRY

NCT05040594 - Evaluate the Efficacy and Safety of Lidocaine-Containing Hyaluronic Acid Filler in the Treatment of Nasolabial Folds. | Biotech Hunter | Biotech Hunter